HHcy promotes hypertension by activating ferroptosis via suppression of the renal H₂S-SLC7A11/GPX4 axis
Life Sciences · 2026
DOI: 10.1016/j.lfs.2026.124247 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Sciences, 2026. Verfasst von Pan Huang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, Capital Center for Children's Health, Capital Medical University, Capital Institute of Pediatrics, Beijing, 100020, China. Hauptthemen laut MEDLINE: Ferroptosis, Hydrogen Sulfide, Hypertension, Amino Acid Transport System y+. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Beijing Natural Science Foundation, National Natural Science Foundation of China.
Abstract (Originalsprache)
Elevated homocysteine (Hcy) is an independent risk factor for hypertension, and kidney is an important organ for Hcy metabolism and blood pressure regulation, and its damage is closely related to the process of hypertension. Recent evidence suggests that ferroptosis, an oxidative stress-related form of cell death, contributes significantly to hypertensive organ damage. However, whether Hcy aggravates renal injury in H-type hypertension by destroying renal hydrogen sulfide (H2S) metabolism and driving ferroptosis is still lack of direct evidence. In this study, the H-type hypertensive rat model induced by high methionine diet combined with HK-2 cell model was studied. We observed a significant increase in blood pressure and plasma Hcy in the Hcy group, accompanied by renal dysfunction and renal tubular injury. Specifically, in the renal tissue of Hcy group rats, the levels of KIM-1, Fe2+ and malondialdehyde (MDA) were increased, glutathione/glutathione disulfide (GSH/GSSG) ratio decreased, SLC7A11 expression was down-regulated, and GPX4 activity was inhibited. Concurrently, H2S levels and cystathionine-beta-synthase (CBS) activity were decreased. In vitro experiments using HK-2 cells confirmed that Hcy could down-regulate the expression of CBS, cystathionine-gamma-lyase (CSE), SLC7A11, GPX4 and GSH/GSSG ratio, and up-regulate MDA and reactive oxygen species (ROS) levels. Treatment with H2S donor (NaHS) or ferroptosis inhibitors (Ferrostatin-1, Fer-1) could rescue these changes. Collectively, our results demonstrate that high Hcy promotes hypertension by suppressing endogenous H2S generation, downregulating the SLC7A11/GPX4 signaling axis, and inducing ferroptosis. These findings reveal a new mechanism by which Hcy aggravates hypertension by inhibiting H2S synthesis and inducing ferroptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neonatology, Capital Center for Children's Health, Capital Medical University, Capital Institute of Pediatrics, Beijing, 100020, China.
- Beijing Municipal Key Laboratory of Child Development and Nutriomics, Capital Center for Children's Health, Capital Medical University, Capital Institute of Pediatrics, Beijing, 100020, China; Capital Institute of Pedia…
- Beijing Municipal Key Laboratory of Child Development and Nutriomics, Capital Center for Children's Health, Capital Medical University, Capital Institute of Pediatrics, Beijing, 100020, China.
- Department of Cardiology, Capital Children's Medical Center & Capital Medical University, Capital Institute of Pediatrics, Beijing, 100020, China. Electronic address: shilin9789@126.com.
- Department of Neonatology, Capital Center for Children's Health, Capital Medical University, Capital Institute of Pediatrics, Beijing, 100020, China. Electronic address: cxswyj@vip.sina.com.
Förderung
- Beijing Natural Science Foundation
- National Natural Science Foundation of China
Zitieren
APA
Huang, P., Zhang, K., Chen, Y., Cheng, J., Yang, S., Shi, L., Wang, Y., & Zhang, Q. (2026). HHcy promotes hypertension by activating ferroptosis via suppression of the renal H₂S-SLC7A11/GPX4 axis. Life Sciences. https://doi.org/10.1016/j.lfs.2026.124247
Vancouver
Huang P, Zhang K, Chen Y, Cheng J, Yang S, Shi L, et al. HHcy promotes hypertension by activating ferroptosis via suppression of the renal H₂S-SLC7A11/GPX4 axis. Life Sciences. 2026. doi:10.1016/j.lfs.2026.124247
BibTeX
@article{Huang2026,
author = {Huang, Pan and Zhang, Kexin and Chen, Ying and Cheng, Jiaxin and Yang, Shuangshuang and Shi, Lin and Wang, Yajuan and Zhang, Qin},
title = {HHcy promotes hypertension by activating ferroptosis via suppression of the renal H₂S-SLC7A11/GPX4 axis},
journal = {Life Sciences},
year = {2026},
doi = {10.1016/j.lfs.2026.124247}
}
EUVIMED